4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001697616-26-000004
Chief Financial Officer sold 1,991 shares at $16.82 ($33,489)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucera Erick · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Sale : show line 1 in the form 10b5-1 | −1,991 | $16.82 | $33,489 | 117,775 | D |
| Open-market sales · 1,991 sh · avg $16.82 · $33,489 | ||||||
Loading xslF345X06/ownership.xml…